Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer
Fondazione IRCCS Istituto Nazionale dei Tumori · Gynecologic Oncology Group · +15 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
120
total citations
- FWCI
- 62.23
- Percentile
- 100%
- References
- 25
Citations per year
Authors
11- GBGiorgio BoganiCorresponding
Fondazione IRCCS Istituto Nazionale dei Tumori
- BJBradley J. Monk
Gynecologic Oncology Group, Florida Cancer Specialists & Research Institute
- MAMatthew A. Powell
Washington University in St. Louis
- SNShannon N. Westin
The University of Texas MD Anderson Cancer Center
- BMBrian M. Slomovitz
Mount Sinai Medical Center
Topics & keywords
Topics
Keywords
- Medicine
- Endometrial cancer
- Oncology
- Immunotherapy
- Internal medicine
- Metastatic breast cancer
- First line treatment
- Gynecology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.